Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, May 17, 2024 · 712,298,199 Articles · 3+ Million Readers

GLP-1 Receptor Agonist Market Size, Share And Growth Analysis For 2024-2033

GLP-1 Receptor Agonist Market Report 2024

GLP-1 Receptor Agonist Global Market Report 2024

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

The glp-1 receptor agonist market size is expected to see strong growth in the next few years. It will grow to $16.82 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%.”
— The Business Research Company

LONDON, GREATER LONDON, UK, May 1, 2024 /EINPresswire.com/ -- The Business Research Company’s “GLP-1 Receptor Agonist Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the glp-1 receptor agonist market size is predicted to reach $16.82 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%.

The growth in the glp-1 receptor agonist market is due to the rising prevalence of diabetes. North America region is expected to hold the largest glp-1 receptor agonist market share. Major players in the glp-1 receptor agonist market include Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co. Ltd.

GLP-1 Receptor Agonist Market Segments
• By Drug Class: Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs
• By Route Of Administration: Parenteral, Oral
• By End Users: Hospitals, Surgical Clinics, Other Users
• By Geography: The global glp-1 receptor agonist market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=9631&type=smp

A GLP-1 receptor agonist is a type of medication that stimulates insulin release at high blood glucose levels and suppresses glucagon secretion under low blood glucose conditions. They are used to treat type 2 diabetes mellitus.

Read More On The GLP-1 Receptor Agonist Global Market Report At:
https://www.thebusinessresearchcompany.com/report/glp-1-receptor-agonist-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. GLP-1 Receptor Agonist Market Characteristics
3. GLP-1 Receptor Agonist Market Trends And Strategies
4. GLP-1 Receptor Agonist Market – Macro Economic Scenario
5. GLP-1 Receptor Agonist Market Size And Growth
……
27. GLP-1 Receptor Agonist Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. GLP-1 Receptor Agonist Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:

Blood Glucose Meters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood Group Typing Global Market Report 2024 https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

Blood And Blood Components Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube

Clinical Trial Management Systems Market

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release